Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Orexigen Therapeutics

Request full access

Biopharmaceutical company focused on the treatment of obesity

San Diego, United StatesFounded 2002Biotech & Life Sciences

About Orexigen Therapeutics

Currax Pharmaceuticals LLC is a specialty pharmaceutical company that focuses on acquiring and commercializing prescription medications within the United States. The company aims to provide access to life-changing medications, enhancing the lives of patients through innovative solutions. Currax operates primarily in the U.S. market, targeting healthcare providers and patients who require specialized prescription drugs. The business model revolves around acquiring existing pharmaceutical products and optimizing their commercial potential through strategic marketing and distribution efforts. Revenue is generated through the sale of these prescription medications to healthcare providers and pharmacies. Currax's commitment to operational excellence is evident from its strong financial performance and strategic acquisitions, such as the acquisition of Nalpropion Pharmaceuticals, Inc. The company also emphasizes a supportive work environment, offering competitive salaries and comprehensive benefits to its employees.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2002
Headquarters
San Diego, United States
Listing
IPO 2007
Sector
Biotech & Life Sciences

Orexigen Therapeutics in the San Diego ecosystem

Live from Dealroom

The Orexigen Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Series B and later5 investors entered at this stage

  • Wasatch Advisors
  • MPM BioImpact
  • Wasatch Ventures
  • The Baupost Group
  • BAUPOST GROUP LIMITED
Team profiled 26 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States69.2%
🇮🇪 Ireland23.1%
🇰🇪 Kenya7.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Orexigen Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Orexigen Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.